Jaguar Health, Inc. (JAGX)
CIK 1585608 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 171.4M shares as of May 15, 2018 (10-Q).
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Pre Funded Warrants | 336,465 | $0.035 | — | — |
| Fourth Pre-Funded Warrants | 92,855 | not tagged | — | — |
| Fifth Pre-Funded Warrants | 82,014 | not tagged | — | — |
| Sixth Pre-Funded Warrants | 64,879 | not tagged | — | — |
| First Pre-Funded Warrants | 44,396 | not tagged | — | — |
| Second Pre-Funded Warrants | 31,767 | not tagged | — | — |
| New Warrants | 26,531 | not tagged | — | — |
| Replacement Notes Warrants | 26,531 | $94.5 | — | — |
| Third Pre-Funded Warrants | 20,555 | not tagged | — | — |
| Warrant Shares | 17,788 | $35 | — | — |
| Common and Wainwright Warrants | 14,075 | $204.4 | — | — |
| January Two Thousand Twenty Six Warrants | 10,000 | $35 | 5y | — |
Tranches exactly as the company dimensioned them in its 10-Q filed May 20, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 278,744 underlying shares, as reported Mar 31, 2026 (10-Q).
Reported exercise price: $0.001 (aggregate figure as tagged; individual tranches vary).
Balance-sheet fair value of warrants: $1,000 as of Mar 31, 2022.
Rough fully diluted estimate: 171.6M = 171.4M O/S + 278,744 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
| Note | Principal | Carrying | Conv. price | Rate | If converted |
|---|---|---|---|---|---|
| March 2025 Convertible Notes | $3.4M | — | $193.73 | — | ~17,550 sh |
| Replacement Notes | $2.6M | — | $193.73 | — | ~13,421 sh |
If every note above converted at its tagged price: ~30,971 new shares on 171.4M currently outstanding. An estimate from principal ÷ conversion price, with inputs carrying different as-of dates; make-whole adjustments, capped calls and partial repurchases are not modeled.
Notes exactly as the company dimensioned them in its 10-Q filed May 20, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 171.4M | May 15, 2018 |
| + Pre Funded Warrants (if exercised) | 336,465 | Jan 16, 2026 |
| + Fourth Pre-Funded Warrants (if exercised) | 92,855 | Jan 16, 2026 |
| + Fifth Pre-Funded Warrants (if exercised) | 82,014 | Jan 16, 2026 |
| + Sixth Pre-Funded Warrants (if exercised) | 64,879 | Jan 16, 2026 |
| + First Pre-Funded Warrants (if exercised) | 44,396 | Jan 16, 2026 |
| + Second Pre-Funded Warrants (if exercised) | 31,767 | Jan 16, 2026 |
| + New Warrants (if exercised) | 26,531 | Jun 24, 2025 |
| + Replacement Notes Warrants (if exercised) | 26,531 | Jun 24, 2025 |
| + Third Pre-Funded Warrants (if exercised) | 20,555 | Jan 16, 2026 |
| + Warrant Shares (if exercised) | 17,788 | Mar 31, 2025 |
| + Common and Wainwright Warrants (if exercised) | 14,075 | May 20, 2025 |
| + January Two Thousand Twenty Six Warrants (if exercised) | 10,000 | Jan 6, 2026 |
| + March 2025 Convertible Notes (if fully converted) | 17,550 | Mar 31, 2025 |
| + Replacement Notes (if fully converted) | 13,421 | Jun 24, 2025 |
| Fully diluted estimate | 172.1M | +0.5% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $107.9Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 13 executed · 4 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full JAGX workspace